Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): A double-blind, randomised, placebo-controlled phase 3 trial

Gregory W. Albers, Rüdiger von Kummer, Thomas Truelsen, Jens Kristian S. Jensen, Gabriela M. Ravn, Bjørn A. Grønning, Hugues Chabriat, Ku Chou Chang, Antonio E. Davalos, Gary A. Ford, James Grotta, Markku Kaste, Lee H. Schwamm, Ashfaq Shuaib

Research output: Contribution to journalArticleResearchpeer-review

83 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): A double-blind, randomised, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences